HEADER ANTIBIOTIC 29-OCT-18 6MVZ
TITLE MLE-PHE-MLE-PHE. LINEAR PRECURSOR OF PSEUDOXYLALLEMYCIN A.
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: LINEAR PRECURSOR OF PSEUDOXYLALLEMYCIN A;
COMPND 3 CHAIN: A;
COMPND 4 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 SYNTHETIC: YES;
SOURCE 3 ORGANISM_SCIENTIFIC: XYLARIA;
SOURCE 4 ORGANISM_TAXID: 37991
KEYWDS TETRAPEPTIDE, N-METHYL LEUCINE, LINEAR PRECURSOR OF
KEYWDS 2 PSEUDOXYLALLEMYCIN A, ANTIBIOTIC
EXPDTA X-RAY DIFFRACTION
AUTHOR A.J.CAMERON,P.W.R.HARRIS,M.A.BRIMBLE,C.J.SQUIRE
REVDAT 2 23-OCT-24 6MVZ 1 REMARK
REVDAT 1 11-SEP-19 6MVZ 0
JRNL AUTH A.J.CAMERON,C.J.SQUIRE,A.GERENTON,L.A.STUBBING,P.W.R.HARRIS,
JRNL AUTH 2 M.A.BRIMBLE
JRNL TITL INVESTIGATIONS OF THE KEY MACROLACTAMISATION STEP IN THE
JRNL TITL 2 SYNTHESIS OF CYCLIC TETRAPEPTIDE PSEUDOXYLALLEMYCIN A.
JRNL REF ORG.BIOMOL.CHEM. V. 17 3902 2019
JRNL REFN ESSN 1477-0539
JRNL PMID 30941386
JRNL DOI 10.1039/C9OB00227H
REMARK 2
REMARK 2 RESOLUTION. 0.83 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : SHELXL
REMARK 3 AUTHORS : G.M.SHELDRICK
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 0.83
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 23.44
REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL
REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0
REMARK 3 CROSS-VALIDATION METHOD : NONE
REMARK 3 FREE R VALUE TEST SET SELECTION : NULL
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF).
REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL
REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL
REMARK 3 FREE R VALUE (NO CUTOFF) : NULL
REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL
REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL
REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL
REMARK 3
REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F).
REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : NULL
REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : NULL
REMARK 3 FREE R VALUE (F>4SIG(F)) : NULL
REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : NULL
REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : NULL
REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 41
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 7
REMARK 3 SOLVENT ATOMS : 1
REMARK 3
REMARK 3 MODEL REFINEMENT.
REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : NULL
REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : NULL
REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : NULL
REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : NULL
REMARK 3 NUMBER OF RESTRAINTS : NULL
REMARK 3
REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES.
REMARK 3 BOND LENGTHS (A) : NULL
REMARK 3 ANGLE DISTANCES (A) : NULL
REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : NULL
REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : NULL
REMARK 3 ZERO CHIRAL VOLUMES (A**3) : NULL
REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : NULL
REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : NULL
REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : NULL
REMARK 3 SIMILAR ADP COMPONENTS (A**2) : NULL
REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : NULL
REMARK 3
REMARK 3 BULK SOLVENT MODELING.
REMARK 3 METHOD USED: NULL
REMARK 3
REMARK 3 STEREOCHEMISTRY TARGET VALUES : NULL
REMARK 3 SPECIAL CASE: NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: FULL LEAST SQUARES REFINEMENT USING
REMARK 3 SHELXL, ANISOTROPIC ATOMS, RIDING HYDROGENS.
REMARK 4
REMARK 4 6MVZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-OCT-18.
REMARK 100 THE DEPOSITION ID IS D_1000237716.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 13-JUL-18
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON
REMARK 200 BEAMLINE : MX2
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.71075
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : PIXEL
REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS
REMARK 200 DATA SCALING SOFTWARE : AIMLESS
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 4332
REMARK 200 RESOLUTION RANGE HIGH (A) : 0.830
REMARK 200 RESOLUTION RANGE LOW (A) : 23.440
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0
REMARK 200 DATA REDUNDANCY : 14.30
REMARK 200 R MERGE (I) : 0.11700
REMARK 200 R SYM (I) : NULL
REMARK 200 FOR THE DATA SET : 22.9000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 0.83
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 0.85
REMARK 200 COMPLETENESS FOR SHELL (%) : 83.8
REMARK 200 DATA REDUNDANCY IN SHELL : 11.90
REMARK 200 R MERGE FOR SHELL (I) : 0.12700
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 FOR SHELL : 16.50
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: AB INITIO PHASING
REMARK 200 SOFTWARE USED: SHELXS
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 24.86
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.64
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: ETHANOL, WATER, EVAPORATION,
REMARK 280 TEMPERATURE 293K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 4.12750
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 11.72300
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 9.58650
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 11.72300
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 4.12750
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 9.58650
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 890 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 400
REMARK 400 COMPOUND
REMARK 400
REMARK 400 THE LINEAR PRECURSOR OF PSEUDOXYLALLEMYCIN A IS PEPTIDE-LIKE, A
REMARK 400 MEMBER OF ANTIBIOTIC CLASS.
REMARK 400
REMARK 400 GROUP: 1
REMARK 400 NAME: LINEAR PRECURSOR OF PSEUDOXYLALLEMYCIN A
REMARK 400 CHAIN: A
REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER
REMARK 400 DESCRIPTION: Mle-Phe-Mle-Phe. Linear precursor of
REMARK 400 pseudoxylallemycin A. The peptide is linear, unlike
REMARK 400 Mle-Phe-Mle-Phe Pseudoxylallemycin A that is cyclic.
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue TFA A 2001
DBREF 6MVZ A 1001 1004 PDB 6MVZ 6MVZ 1001 1004
SEQRES 1 A 4 MLE PHE MLE PHE
HET MLE A1001 9
HET MLE A1003 9
HET TFA A2001 7
HETNAM MLE N-METHYLLEUCINE
HETNAM TFA TRIFLUOROACETIC ACID
FORMUL 1 MLE 2(C7 H15 N O2)
FORMUL 2 TFA C2 H F3 O2
FORMUL 3 HOH *(H2 O)
LINK C MLE A1001 N PHE A1002 1555 1555 1.33
LINK C PHE A1002 N MLE A1003 1555 1555 1.34
LINK C MLE A1003 N PHE A1004 1555 1555 1.36
SITE 1 AC1 5 MLE A1001 PHE A1002 MLE A1003 PHE A1004
SITE 2 AC1 5 HOH A3001
CRYST1 8.255 19.173 23.446 90.00 90.00 90.00 P 21 21 21 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.121139 0.000000 0.000000 0.00000
SCALE2 0.000000 0.052157 0.000000 0.00000
SCALE3 0.000000 0.000000 0.042651 0.00000
HETATM 1 N MLE A1001 -1.988 15.766 19.167 1.00 3.46 N
ANISOU 1 N MLE A1001 306 436 496 7 -34 -40 N
HETATM 2 CN MLE A1001 -1.911 16.924 18.234 1.00 4.02 C
ANISOU 2 CN MLE A1001 403 455 577 16 -66 5 C
HETATM 3 CA MLE A1001 -0.663 15.233 19.589 1.00 3.44 C
ANISOU 3 CA MLE A1001 321 432 475 20 -31 -32 C
HETATM 4 CB MLE A1001 -0.898 14.158 20.669 1.00 3.83 C
ANISOU 4 CB MLE A1001 406 453 511 2 17 10 C
HETATM 5 CG MLE A1001 0.374 13.573 21.288 1.00 4.10 C
ANISOU 5 CG MLE A1001 441 534 489 44 -22 10 C
HETATM 6 CD1 MLE A1001 1.110 14.593 22.142 1.00 5.16 C
ANISOU 6 CD1 MLE A1001 601 631 613 -43 -156 16 C
HETATM 7 CD2 MLE A1001 0.024 12.344 22.146 1.00 5.28 C
ANISOU 7 CD2 MLE A1001 718 553 616 54 -42 90 C
HETATM 8 C MLE A1001 0.027 14.627 18.372 1.00 3.27 C
ANISOU 8 C MLE A1001 319 396 455 13 -15 3 C
HETATM 9 O MLE A1001 -0.618 13.872 17.611 1.00 3.80 O
ANISOU 9 O MLE A1001 312 525 522 -36 -14 -107 O
ATOM 10 N PHE A1002 1.313 14.938 18.221 1.00 3.16 N
ANISOU 10 N PHE A1002 274 421 434 5 9 -29 N
ATOM 11 CA PHE A1002 2.117 14.450 17.105 1.00 3.40 C
ANISOU 11 CA PHE A1002 295 469 450 25 0 -59 C
ATOM 12 C PHE A1002 3.285 13.617 17.674 1.00 3.38 C
ANISOU 12 C PHE A1002 265 463 481 9 -20 -39 C
ATOM 13 O PHE A1002 4.253 14.238 18.149 1.00 4.85 O
ANISOU 13 O PHE A1002 382 446 905 2 -206 -34 O
ATOM 14 CB PHE A1002 2.706 15.619 16.292 1.00 4.09 C
ANISOU 14 CB PHE A1002 345 567 550 -10 32 56 C
ATOM 15 CG PHE A1002 1.665 16.560 15.713 1.00 3.75 C
ANISOU 15 CG PHE A1002 309 518 514 -33 12 68 C
ATOM 16 CD1 PHE A1002 1.127 16.338 14.447 1.00 4.01 C
ANISOU 16 CD1 PHE A1002 421 521 491 -15 22 -6 C
ATOM 17 CD2 PHE A1002 1.263 17.689 16.421 1.00 4.04 C
ANISOU 17 CD2 PHE A1002 452 513 478 -38 -30 35 C
ATOM 18 CE1 PHE A1002 0.208 17.235 13.901 1.00 4.10 C
ANISOU 18 CE1 PHE A1002 431 549 483 -19 -25 39 C
ATOM 19 CE2 PHE A1002 0.345 18.582 15.881 1.00 4.22 C
ANISOU 19 CE2 PHE A1002 532 462 512 -19 43 6 C
ATOM 20 CZ PHE A1002 -0.184 18.354 14.613 1.00 4.28 C
ANISOU 20 CZ PHE A1002 466 492 571 12 -31 106 C
HETATM 21 N MLE A1003 3.221 12.283 17.686 1.00 3.47 N
ANISOU 21 N MLE A1003 243 449 547 -3 -28 -49 N
HETATM 22 CN MLE A1003 2.107 11.519 17.092 1.00 4.27 C
ANISOU 22 CN MLE A1003 375 434 716 -30 -64 -39 C
HETATM 23 CA MLE A1003 4.402 11.518 18.168 1.00 3.56 C
ANISOU 23 CA MLE A1003 340 447 485 -22 -34 -11 C
HETATM 24 CB MLE A1003 4.091 10.495 19.268 1.00 4.09 C
ANISOU 24 CB MLE A1003 451 461 549 -17 -6 19 C
HETATM 25 CG MLE A1003 4.714 10.855 20.618 1.00 4.27 C
ANISOU 25 CG MLE A1003 458 537 532 -22 3 11 C
HETATM 26 CD1 MLE A1003 4.659 9.698 21.604 1.00 4.99 C
ANISOU 26 CD1 MLE A1003 606 586 589 51 14 48 C
HETATM 27 CD2 MLE A1003 4.101 12.108 21.215 1.00 5.82 C
ANISOU 27 CD2 MLE A1003 897 597 587 41 60 -71 C
HETATM 28 C MLE A1003 5.033 10.893 16.918 1.00 3.49 C
ANISOU 28 C MLE A1003 307 393 547 18 36 34 C
HETATM 29 O MLE A1003 4.705 9.782 16.486 1.00 4.05 O
ANISOU 29 O MLE A1003 423 429 596 -30 25 -51 O
ATOM 30 N PHE A1004 5.932 11.681 16.278 1.00 3.60 N
ANISOU 30 N PHE A1004 368 433 486 -35 26 -30 N
ATOM 31 CA PHE A1004 6.466 11.344 14.967 1.00 3.73 C
ANISOU 31 CA PHE A1004 360 490 483 27 2 -34 C
ATOM 32 C PHE A1004 7.501 10.238 15.005 1.00 3.79 C
ANISOU 32 C PHE A1004 378 486 490 -18 18 18 C
ATOM 33 O PHE A1004 8.030 9.823 16.014 1.00 4.24 O
ANISOU 33 O PHE A1004 436 540 539 9 -41 47 O
ATOM 34 CB PHE A1004 7.087 12.596 14.319 1.00 4.08 C
ANISOU 34 CB PHE A1004 383 546 528 -13 39 2 C
ATOM 35 CG PHE A1004 6.070 13.618 13.854 1.00 3.84 C
ANISOU 35 CG PHE A1004 385 529 459 -7 12 42 C
ATOM 36 CD1 PHE A1004 5.165 13.316 12.849 1.00 4.80 C
ANISOU 36 CD1 PHE A1004 609 548 558 29 -77 -63 C
ATOM 37 CD2 PHE A1004 6.083 14.915 14.357 1.00 4.12 C
ANISOU 37 CD2 PHE A1004 418 502 552 -60 37 25 C
ATOM 38 CE1 PHE A1004 4.280 14.266 12.363 1.00 5.01 C
ANISOU 38 CE1 PHE A1004 590 611 590 88 -149 14 C
ATOM 39 CE2 PHE A1004 5.227 15.884 13.848 1.00 4.58 C
ANISOU 39 CE2 PHE A1004 483 522 632 3 48 23 C
ATOM 40 CZ PHE A1004 4.332 15.565 12.837 1.00 4.78 C
ANISOU 40 CZ PHE A1004 521 642 546 84 37 60 C
ATOM 41 OXT PHE A1004 7.761 9.819 13.767 1.00 4.72 O
ANISOU 41 OXT PHE A1004 569 598 518 154 21 1 O
TER 42 PHE A1004
HETATM 43 C1 TFA A2001 10.847 8.106 13.529 1.00 3.89 C
ANISOU 43 C1 TFA A2001 397 506 488 -1 37 -14 C
HETATM 44 C2 TFA A2001 11.368 9.443 12.938 1.00 4.30 C
ANISOU 44 C2 TFA A2001 452 571 513 -35 -29 6 C
HETATM 45 O TFA A2001 9.614 8.001 13.619 1.00 4.59 O
ANISOU 45 O TFA A2001 372 551 717 38 53 69 O
HETATM 46 F1 TFA A2001 12.674 9.438 12.668 1.00 5.59 F
ANISOU 46 F1 TFA A2001 494 689 814 -98 58 72 F
HETATM 47 F2 TFA A2001 10.723 9.750 11.802 1.00 5.65 F
ANISOU 47 F2 TFA A2001 677 758 583 -99 -82 192 F
HETATM 48 F3 TFA A2001 11.156 10.447 13.792 1.00 6.18 F
ANISOU 48 F3 TFA A2001 914 531 764 -63 72 -110 F
HETATM 49 OXT TFA A2001 11.705 7.276 13.897 1.00 4.33 O
ANISOU 49 OXT TFA A2001 397 572 577 18 -17 55 O
HETATM 50 O HOH A3001 14.071 7.413 15.349 1.00 4.53 O
ANISOU 50 O HOH A3001 562 433 622 62 -90 -37 O
CONECT 1 2 3
CONECT 2 1
CONECT 3 1 4 8
CONECT 4 3 5
CONECT 5 4 6 7
CONECT 6 5
CONECT 7 5
CONECT 8 3 9 10
CONECT 9 8
CONECT 10 8
CONECT 12 21
CONECT 21 12 22 23
CONECT 22 21
CONECT 23 21 24 28
CONECT 24 23 25
CONECT 25 24 26 27
CONECT 26 25
CONECT 27 25
CONECT 28 23 29 30
CONECT 29 28
CONECT 30 28
CONECT 43 44 45 49
CONECT 44 43 46 47 48
CONECT 45 43
CONECT 46 44
CONECT 47 44
CONECT 48 44
CONECT 49 43
MASTER 199 0 3 0 0 0 2 6 49 1 28 1
END